Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax® challenge in vaccinia-naïve and vaccinia-immune individuals
Janie Parrino, Barney S. Graham(National Institutes of Health), Lin Gu(Cancer Research And Biostatistics), Mary E. Enama(National Institutes of Health), Brenda Larkin(National Institutes of Health), Lewis McCurdy(National Institutes of Health), Ingelise J. Gordon(National Institute of Allergy and Infectious Diseases), Steven E. Rucker(National Institutes of Health), Robert T. Bailer(National Institutes of Health), Mario Roederer(National Institutes of Health), Zoe Moodie(Fred Hutch Cancer Center), Lihan Yan(Emmes (United States)), Richard A. Koup(Aaron Diamond AIDS Research Center)
Cited by 95
Related Papers
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
|Science|2020|9.8k
A human memory T cell subset with stem cell–like properties
|Nature Medicine|2011|2k
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|Science|2010|1.8k
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
|Journal of Immunological Methods|2003|1.6k